EpiAging

Short answer: the biomarkers that most reliably track longevity are those that reflect cardiometabolic health (glucose metabolism, lipids, blood pressure risk), systemic inflammation, kidney and liver function, hematologic status, and certain micronutrients/hormones. Several emerging tests (ApoB/Lp(a), NMR particle counts, IL‑6, telomere length, epigenetic clocks) add useful information for personalized risk. Below is a prioritized, practical list and where to get tested. High-priority (strong evidence for predicting mortality / age-related disease) Glycemic control: fasting glucose, fasting insulin (or HOMA‑IR), and HbA1c Why: chronic hyperglycemia/insulin resistance is strongly linked to cardiovascular disease, dementia, and shorter lifespan. Where to test: standard labs (Quest, LabCorp); insulin often available with routine bloodwork. Lipids and atherogenic burden: LDL‑cholesterol, triglycerides, HDL, plus ApoB and Lp(a) when possible Why: atherogenic lipoproteins drive cardiovascular mortality; ApoB and Lp(a) give additional risk beyond LDL. Where: LDL/HDL/TG via Quest/LabCorp; ApoB and Lp(a) offered by Quest, LabCorp, Boston Heart Diagnostics. Inflammation: high‑sensitivity C‑reactive protein (hs‑CRP) Why: chronic low‑grade inflammation predicts cardiovascular events and mortality. Where: standard labs (Quest, LabCorp). For deeper cytokine profiling (IL‑6, TNF‑α), see specialized labs below. Kidney function: serum creatinine, eGFR, and cystatin C (if available) Why: renal dysfunction strongly increases mortality risk. Where: routine labs; cystatin C available via Quest/LabCorp and some specialty labs. Liver health: ALT, AST, GGT, alkaline phosphatase, bilirubin Why: liver enzyme abnormalities correlate with metabolic dysfunction and mortality risk. Where: routine labs. Hematology and red‑cell markers: CBC including hemoglobin, hematocrit, red cell distribution width (RDW) Why: anemia and elevated RDW are independent predictors of mortality. Where: routine labs. Moderate / actionable biomarkers (add important nuance) Advanced lipoprotein testing: LDL particle number (LDL‑P) or NMR lipoprofile Why: particle number can predict risk better than calculated LDL in many people. Where: LabCorp (NMR LipoProfile/LipoScience historically), Quest/Boston Heart for advanced lipid panels. Omega‑3 index Why: higher omega‑3 index is associated with lower cardiovascular risk and may reflect dietary quality. Where: OmegaQuant (widely used specialty service). Ferritin and iron studies (serum iron, transferrin saturation) Why: iron excess and deficiency both link to adverse outcomes. Where: routine labs. Vitamin D (25‑OH vitamin D) Why: low levels associate with higher mortality and many age‑related conditions. Where: routine labs; also direct-to-consumer kits. Emerging / research‑grade markers (useful for deeper phenotyping) Lp(a) (if not already measured), ApoB (if not already measured) Why: genetically determined risk; guides CV prevention decisions. IL‑6 and other inflammatory cytokines Why: IL‑6 often outperforms CRP in predictive power for aging-related outcomes; cytokine panels are still evolving. Where: specialized labs (Cleveland HeartLab, ARUP, Boston Heart) or research labs. Homocysteine Why: associated with vascular and cognitive risk in some studies. Where: routine labs. Biomarkers of biological age: DNA methylation clocks (epigenetic age), GlycanAge, telomere length Why: may quantify biological (vs chronological) aging; useful for tracking interventions but not yet standard of care. Where: TruDiagnostic (methylation/epigenetic age), EpiAging services, GlycanAge, TeloYears or Life Length (telomeres). Composite scores: multi‑marker risk tests (cardio metabolic risk panels, inflammatory risk scores) Why: combining markers yields better prediction than any single value. Where: commercial services like InsideTracker, WellnessFX, Boston Heart Diagnostics, Cleveland HeartLab. Practical testing services and why you might choose them Quest Diagnostics and LabCorp — broad coverage, most standard and many specialty tests, accepted by clinicians and insurers. InsideTracker — consumer‑focused: selects tests and gives actionable, evidence‑based lifestyle recommendations (good for people who want interpretation + coaching). Boston Heart Diagnostics and Cleveland HeartLab — cardiometabolic specialists offering advanced lipid testing, inflammation panels, and clinician reports focused on cardiovascular risk. OmegaQuant — gold standard for omega‑3 index testing. TruDiagnostic (or similar providers) — for DNA methylation/epigenetic age testing if you want a biological‑age readout and longitudinal tracking. TeloYears or Life Length — telomere length testing providers (research/monitoring use rather than clinical decision‑making). Everlywell, LetsGetChecked — convenient at‑home kits for some routine tests (glucose, lipids, HbA1c, vitamin D, etc.), but limited for advanced assays. How to use this information Prioritize glycemic markers, standard lipid panel (plus ApoB/Lp(a) if risk factors present), hs‑CRP, kidney and liver tests, CBC, vitamin D, and omega‑3 index when possible. Repeat testing based on risk: annually for routine monitoring if healthy; more often if abnormal or if starting an intervention. Interpret results in the context of age, sex, family history and medications. Don’t chase single numbers in isolation — trends and multi‑marker patterns matter more. Discuss abnormal or borderline findings with a clinician before starting medications or supplements. If you want, tell me your age, sex, major health history (e.g., diabetes, heart disease, family history), and whether you prefer clinic or at‑home testing, and I’ll recommend a specific test panel and one or two services/labs to use.

Mentioned in position 10 of 15